Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial
- PMID: 27898215
- DOI: 10.1164/rccm.201607-1404OC
Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial
Abstract
Rationale: Patients with malignant pleural effusions have significant dyspnea and shortened life expectancy. Indwelling pleural catheters allow patients to drain pleural fluid at home and can lead to autopleurodesis. The optimal drainage frequency to achieve autopleurodesis and freedom from catheter has not been determined.
Objectives: To determine whether an aggressive daily drainage strategy is superior to the current standard every other day drainage of pleural fluid in achieving autopleurodesis.
Methods: Patients were randomized to either an aggressive drainage (daily drainage; n = 73) or standard drainage (every other day drainage; n = 76) of pleural fluid via a tunneled pleural catheter.
Measurements and main results: The primary outcome was the incidence of autopleurodesis following the placement of the indwelling pleural catheters. The rate of autopleurodesis, defined as complete or partial response based on symptomatic and radiographic changes, was greater in the aggressive drainage arm than the standard drainage arm (47% vs. 24%, respectively; P = 0.003). Median time to autopleurodesis was shorter in the aggressive arm (54 d; 95% confidence interval, 34-83) as compared with the standard arm (90 d; 95% confidence interval, 70 to nonestimable). Rate of adverse events, quality of life, and patient satisfaction were not significantly different between the two arms.
Conclusions: Among patients with malignant pleural effusion, daily drainage of pleural fluid via an indwelling pleural catheter led to a higher rate of autopleurodesis and faster time to liberty from catheter. Clinical trial registered with www.clinicaltrials.gov (NCT 00978939).
Keywords: indwelling pleural catheter; malignant pleural effusions; pleurodesis.
Comment in
-
The Evolving Role of the Indwelling Tunneled Pleural Catheter. A Means to an End.Am J Respir Crit Care Med. 2017 Apr 15;195(8):976-978. doi: 10.1164/rccm.201612-2405ED. Am J Respir Crit Care Med. 2017. PMID: 28409687 No abstract available.
-
Reply to Gilbert et al.: The Impact of the ASAP Trial: Maybe We Shouldn't Act So Quickly.Am J Respir Crit Care Med. 2018 Jan 1;197(1):143-144. doi: 10.1164/rccm.201706-1190LE. Am J Respir Crit Care Med. 2018. PMID: 28692302 No abstract available.
-
The Impact of the ASAP Trial: Maybe We Shouldn't Act So Quickly.Am J Respir Crit Care Med. 2018 Jan 1;197(1):142-143. doi: 10.1164/rccm.201705-0956LE. Am J Respir Crit Care Med. 2018. PMID: 28692344 No abstract available.
Similar articles
-
Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.Lancet Respir Med. 2018 Sep;6(9):671-680. doi: 10.1016/S2213-2600(18)30288-1. Epub 2018 Jul 20. Lancet Respir Med. 2018. PMID: 30037711 Clinical Trial.
-
Silver Nitrate-coated versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial.Ann Am Thorac Soc. 2022 Oct;19(10):1722-1729. doi: 10.1513/AnnalsATS.202111-1301OC. Ann Am Thorac Soc. 2022. PMID: 35363591 Clinical Trial.
-
Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.BMJ Open. 2016 Jul 5;6(7):e011480. doi: 10.1136/bmjopen-2016-011480. BMJ Open. 2016. PMID: 27381209 Free PMC article. Clinical Trial.
-
The use of tunneled pleural catheters in the treatment of pleural effusions.Curr Opin Pulm Med. 2011 Jul;17(4):237-41. doi: 10.1097/MCP.0b013e3283463dac. Curr Opin Pulm Med. 2011. PMID: 21460729 Review.
-
Indwelling Pleural Catheters.Clin Chest Med. 2021 Dec;42(4):739-750. doi: 10.1016/j.ccm.2021.08.009. Clin Chest Med. 2021. PMID: 34774179 Review.
Cited by
-
Malignant pleural effusion: current understanding and therapeutic approach.Respir Res. 2024 Jan 19;25(1):47. doi: 10.1186/s12931-024-02684-7. Respir Res. 2024. PMID: 38243259 Free PMC article. Review.
-
Patient-Reported Outcomes in Pleural Effusions: A Systematic Review.Cureus. 2024 Jan 17;16(1):e52430. doi: 10.7759/cureus.52430. eCollection 2024 Jan. Cureus. 2024. PMID: 38371010 Free PMC article. Review.
-
Malignant Pleural Effusion: Diagnosis and Management.Can Respir J. 2020 Sep 23;2020:2950751. doi: 10.1155/2020/2950751. eCollection 2020. Can Respir J. 2020. PMID: 33273991 Free PMC article. Review.
-
Evaluation of a Digital Health Model of Care for the Management of Adults With Symptomatic Malignant Pleural Effusion.Respirol Case Rep. 2025 Jun 18;13(6):e70194. doi: 10.1002/rcr2.70194. eCollection 2025 Jun. Respirol Case Rep. 2025. PMID: 40538923 Free PMC article. Clinical Trial.
-
Progress in Mechanistic Research and the Use of Traditional Chinese Medicine in Treating Malignant Pleural Effusion.Cancer Manag Res. 2025 Jul 15;17:1377-1388. doi: 10.2147/CMAR.S529467. eCollection 2025. Cancer Manag Res. 2025. PMID: 40692944 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical